Literature DB >> 23785160

Amygdala activation for eye contact despite complete cortical blindness.

Nicolas Burra1, Alexis Hervais-Adelman, Dirk Kerzel, Marco Tamietto, Beatrice de Gelder, Alan J Pegna.   

Abstract

Cortical blindness refers to the loss of vision that occurs after destruction of the primary visual cortex. Although there is no sensory cortex and hence no conscious vision, some cortically blind patients show amygdala activation in response to facial or bodily expressions of emotion. Here we investigated whether direction of gaze could also be processed in the absence of any functional visual cortex. A well-known patient with bilateral destruction of his visual cortex and subsequent cortical blindness was investigated in an fMRI paradigm during which blocks of faces were presented either with their gaze directed toward or away from the viewer. Increased right amygdala activation was found in response to directed compared with averted gaze. Activity in this region was further found to be functionally connected to a larger network associated with face and gaze processing. The present study demonstrates that, in human subjects, the amygdala response to eye contact does not require an intact primary visual cortex.

Entities:  

Mesh:

Year:  2013        PMID: 23785160      PMCID: PMC6618602          DOI: 10.1523/JNEUROSCI.3994-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

1.  The dual nature of eye contact: to see and to be seen.

Authors:  Aki Myllyneva; Jari K Hietanen
Journal:  Soc Cogn Affect Neurosci       Date:  2015-06-08       Impact factor: 3.436

2.  Early and late cortical responses to directly gazing faces are task dependent.

Authors:  Nicolas Burra; David Framorando; Alan J Pegna
Journal:  Cogn Affect Behav Neurosci       Date:  2018-08       Impact factor: 3.282

Review 3.  Comparative Perspectives on Oxytocin and Vasopressin Receptor Research in Rodents and Primates: Translational Implications.

Authors:  Sara M Freeman; Larry J Young
Journal:  J Neuroendocrinol       Date:  2016-04       Impact factor: 3.627

Review 4.  Novel brain imaging approaches to understand acquired and congenital neuro-ophthalmological conditions.

Authors:  Rebecca S Millington; Sara Ajina; Holly Bridge
Journal:  Curr Opin Neurol       Date:  2014-02       Impact factor: 5.710

5.  Pubertal Testosterone and Brain Response to Faces in Young Adulthood: An Interplay between Organizational and Activational Effects in Young Men.

Authors:  Zhijie Liao; Steven Tilley; Andrei Mouraviev; Ammar Khairullah; Tomas Paus
Journal:  J Neurosci       Date:  2021-02-15       Impact factor: 6.167

6.  Neurofunctional Signature of Hyperfamiliarity for Unknown Faces.

Authors:  Elisa Negro; Federico D'Agata; Paola Caroppo; Mario Coriasco; Federica Ferrio; Alessia Celeghin; Matteo Diano; Elisa Rubino; Beatrice de Gelder; Innocenzo Rainero; Lorenzo Pinessi; Marco Tamietto
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

7.  Emotion processing in Parkinson's disease: a three-level study on recognition, representation, and regulation.

Authors:  Ivan Enrici; Mauro Adenzato; Rita B Ardito; Antonia Mitkova; Marco Cavallo; Maurizio Zibetti; Leonardo Lopiano; Lorys Castelli
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

8.  Subcortical regions of the human visual system do not process faces holistically.

Authors:  Rebeka C Almasi; Marlene Behrmann
Journal:  Brain Cogn       Date:  2021-04-29       Impact factor: 2.682

9.  Early changes in corticospinal excitability when seeing fearful body expressions.

Authors:  Sara Borgomaneri; Francesca Vitale; Alessio Avenanti
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

10.  Perception of social cues of danger in autism spectrum disorders.

Authors:  Nicole R Zürcher; Ophélie Rogier; Jasmine Boshyan; Loyse Hippolyte; Britt Russo; Nanna Gillberg; Adam Helles; Torsten Ruest; Eric Lemonnier; Christopher Gillberg; Nouchine Hadjikhani
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.